These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21663530)

  • 1. Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors.
    Di Fede G; Bronte G; Rizzo S; Rolfo Cervetto C; Cocorullo G; Gulotta G; Bazan V; Russo A
    Expert Opin Biol Ther; 2011 Nov; 11(11):1433-45. PubMed ID: 21663530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of antibodies or their fragments for the treatment of tumors].
    Douillard JY; Chatal JF
    Bull Cancer; 1998 Nov; 85(11):951-9. PubMed ID: 9951422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody engineering: facing new challenges in cancer therapy.
    Sanz L; Cuesta AM; Compte M; Alvarez-Vallina L
    Acta Pharmacol Sin; 2005 Jun; 26(6):641-8. PubMed ID: 15916728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology evaluation: edrecolomab, Centocor Inc.
    Abicht A; Lochmüller H
    Curr Opin Mol Ther; 2000 Oct; 2(5):593-600. PubMed ID: 11249762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies for medical oncology: a few critical perspectives.
    Belda-Iniesta C; Ibáñez de Cáceres I; de Castro J
    Clin Transl Oncol; 2011 Feb; 13(2):84-7. PubMed ID: 21324795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using antibodies to target cancer therapeutics.
    Goldenberg DM; Sharkey RM
    Expert Opin Biol Ther; 2012 Sep; 12(9):1173-90. PubMed ID: 22650606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario.
    Bronte G; Sortino G; Passiglia F; Rizzo S; Lo Vullo F; Galvano A; Bazan V; Rolfo C; Russo A
    Expert Opin Biol Ther; 2015 Jan; 15(1):45-59. PubMed ID: 25250872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal antibody for cancer treatment].
    Achiwa H; Sato S; Ueda R
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):495-501. PubMed ID: 11977531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies in the therapy of colon cancer.
    Welt S; Ritter G
    Semin Oncol; 1999 Dec; 26(6):683-90. PubMed ID: 10606261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic application of monoclonal antibodies in cancer: advances and challenges.
    Modjtahedi H; Ali S; Essapen S
    Br Med Bull; 2012; 104():41-59. PubMed ID: 23118261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 blockade: autoimmunity as treatment.
    Kapadia D; Fong L
    J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer immunotherapy.
    Baxevanis CN; Perez SA; Papamichail M
    Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody and immunotherapy in oncology. Which patients benefit?].
    Schlimok G
    MMW Fortschr Med; 2001 Jun; 143(25):24-8. PubMed ID: 11468992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-specific antibodies for cancer immunotherapy.
    Jachimowicz RD; Borchmann S; Rothe A
    BioDrugs; 2014 Aug; 28(4):331-43. PubMed ID: 24638872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.